Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraproteinaemic neuropathies.

A J Steck1, B Erne, J M Gabriel

  • 1Department of Neurology, University Hospital of Basel, Switzerland. steck@ubaclu.unibas.ch

Brain Pathology (Zurich, Switzerland)
|April 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.

Experimental neurology·2018
Same author

Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.

Brain, behavior, and immunity·2015
Same author

Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry.

Cell death & disease·2012
Same author

The myelin protein MAL affects peripheral nerve myelination: a new player influencing p75 neurotrophin receptor expression.

The European journal of neuroscience·2009
Same author

Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease.

European journal of neurology·2009
Same author

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

European journal of neurology·2009

Paraproteinaemic neuropathies are reviewed, with strong evidence linking IgM gammopathies targeting myelin associated glycoprotein (MAG) to nerve damage. Unresolved questions remain regarding antibody mechanisms and other paraprotein types.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Paraproteinaemic neuropathies involve immune system dysregulation affecting the nervous system.
  • Understanding molecular pathogenesis is crucial for characterizing clinical syndromes.

Purpose of the Study:

  • To review clinical and pathological features of paraproteinaemic neuropathies.
  • To discuss recent experimental findings and molecular insights.
  • To explore the pathogenesis of these complex neurological disorders.

Main Methods:

  • Review of clinical and pathological data.
  • Analysis of experimental findings at the molecular level.
  • Examination of antibody specificities and their targets.

Related Experiment Videos

Main Results:

  • Convincing evidence links IgM monoclonal gammopathies against myelin associated glycoprotein (MAG) to demyelinating polyneuropathy.
  • Other IgM specificities (neurofilaments, gangliosides) and IgG/IgA antibodies have identified roles, but require further elucidation.
  • Paraneoplastic manifestations of osteosclerotic myelomas offer insights into neuro-immune interactions.

Conclusions:

  • IgM anti-MAG antibodies are a key cause of paraproteinaemic neuropathies, though mechanisms of nerve damage are not fully understood.
  • Further research is needed to clarify the pathogenetic roles of other paraproteins and their specificities.
  • Investigating rare myelomas provides valuable insights into immune-nervous system interplay in neuropathies.